Epanolol
Epanolol is a beta blocker.[1]
| Names | |
|---|---|
| IUPAC name
(RS)-N-[2-([3-(2-cyanophenoxy)-2-hydroxypropyl]amino)ethyl]-2-(4-hydroxyphenyl)acetamide | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
| KEGG | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C20H23N3O4 | |
| Molar mass | 369.41432 |
| Pharmacology | |
| C07AB10 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Synthesis
Amide-ester interchange between Methyl 4-benzyloxyphenylacetate [68641-16-7] (1) and ethylenediamine [107-15-3] (2) gives N-(2-aminoethyl)-2-(4-phenylmethoxyphenyl)acetamide, PC12841758 (3). The treatment of 2-Cyanophenol [611-20-1] (4) with epichlorohydrin in lye gives 2-glycidyloxybenzonitrile [38465-16-6] (5). Convergent synthesis between the two sections gives N-[2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-2-(4-phenylmethoxyphenyl)acetamide, PC134990214 (6). Lastly, catalytic hydrogenation splits the benzyl protecting group completing the synthesis of Epanolol (7).
See also
References
- Hosie, J.; Scott, A. K.; Petrie, J. C.; Cockshott, I. D. (1990). "Pharmacokinetics of epanolol after acute and chronic oral dosing in elderly patients with stable angina pectoris". British Journal of Clinical Pharmacology. 29 (3): 333–337. doi:10.1111/j.1365-2125.1990.tb03644.x. PMC 1380134. PMID 1968755.
- Pento, JT; Day, BW; Epanolol. Drugs Fut 1985, 10, 5, 392.
- Lare MS, Smith LH. Beta-adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido) alkyl]amino]-2-propanols. J Med Chem. 1982 Nov;25(11):1286-92. doi: 10.1021/jm00353a004. PMID: 6128420.
- Harold Smith Leslie, GB1573359 (1980 to Imperial Chemical Industries Ltd).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.